Somaxon Pharmaceuticals, Inc. (SOMX)

[DewDiligence]

What a crock! Silenor is simply a low-dose formulation of doxepin, an antidepressant approved by the FDA in 1969. That right, 41 years ago. Silenor won’t sell anywhere near the $500M forecast in the write-up you posted. I doubt it will sell even one-tenth of that amount.